Wendan decoction for primary insomnia: Protocol for a systematic review and meta-analysis
- PMID: 29382025
- PMCID: PMC5709024
- DOI: 10.1097/MD.0000000000008906
Wendan decoction for primary insomnia: Protocol for a systematic review and meta-analysis
Abstract
Background: Insomnia is a widespread complaint in the general population. Wendan decoction has been widely applied in the treatment of primary insomnia. However, to our knowledge, there has been no systematic review or meta-analysis of randomized controlled trails regarding the effectiveness of this treatment. Here, we provide a protocol to evaluate the efficacy and safety of Wendan decoction for primary insomnia.
Methods and analysis: Relevant randomized controlled trials in 5 English databases [EMBASE, the Cochrane Central Register of Controlled Trials (Cochrane Library), PubMed, the Allied and Complementary Medicine Databases (AMED), and the Cumulative Index to Nursing and Allied Health Literature (CINAHL)], 4 Chinese databases [Chinese Biomedical Literature Database (CBM), Chinese Medical Current Content (CMCC), China National Knowledge Infrastructure (CNKI), and Wanfang Database] will be comprehensively searched by 2 researchers in October 2017. The therapeutic effects according to the Pittsburgh Sleep Quality Index (PSQI) will be accepted as the primary outcomes. We will use RevMan V.5.3 software as well to compute the data synthesis carefully when a metaanalysis is allowed.
Results: This study will provide a high-quality synthesis of current evidence of Wendan decoction for primary insomnia from several aspects including PSQI, the total scores of the Insomnia Severity Index (ISI), syndrome according to standards for assessing Traditional Chinese medicine and adverse events.
Conclusion: The conclusion of our systematic review will provide evidence to judge whether Wendan decoction is an effective intervention for patient with primary insomnia.
Ethics and dissemination: The outcomes of this systematic review will offer implications of the use of Wendan decoction treatment for primary insomnia patients. This knowledge informing recommendations will be provided by researchers who are interested in the treatment of primary insomnia. The results of this study will be disseminated through presentation at a conference and publication of the data in a peer-reviewed journal.
Prospero registration number: PROSPERO CRD 42017065664.
Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Guipi decoction for insomnia: Systematic review and meta-analysis.Medicine (Baltimore). 2020 Jul 2;99(27):e21031. doi: 10.1097/MD.0000000000021031. Medicine (Baltimore). 2020. PMID: 32629727 Free PMC article.
-
Guizhi Gancao Longgu Muli decoction for insomnia: A protocol for a systematic review.Medicine (Baltimore). 2020 Feb;99(9):e19198. doi: 10.1097/MD.0000000000019198. Medicine (Baltimore). 2020. PMID: 32118720 Free PMC article.
-
Suan-Zao-Ren decoction for insomnia: A protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2020 Aug 21;99(34):e21658. doi: 10.1097/MD.0000000000021658. Medicine (Baltimore). 2020. PMID: 32846778 Free PMC article.
-
Traditional Chinese medicine formula Xiaoqinglong decoction for cough caused by COVID-19: A protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2020 Nov 25;99(48):e23261. doi: 10.1097/MD.0000000000023261. Medicine (Baltimore). 2020. PMID: 33235084 Free PMC article.
-
Efficacy and safety of Shumian capsules in treating insomnia: A systematic review and meta-analysis.Medicine (Baltimore). 2021 Dec 17;100(50):e28194. doi: 10.1097/MD.0000000000028194. Medicine (Baltimore). 2021. PMID: 34918675 Free PMC article.
Cited by
-
Wen Dan Tang: A Potential Jing Fang Decoction for Headache Disorders?Medicines (Basel). 2022 Mar 4;9(3):22. doi: 10.3390/medicines9030022. Medicines (Basel). 2022. PMID: 35323721 Free PMC article. Review.
-
New Method for Insomnia Mongolian Mind-Body Interactive Psychotherapy in the Assessment of Chronic Insomnia: A Retrospective Study.Adv Ther. 2018 Jul;35(7):993-1000. doi: 10.1007/s12325-018-0726-9. Epub 2018 Jun 19. Adv Ther. 2018. PMID: 29923046 Free PMC article.
-
The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model.Front Pharmacol. 2024 Jan 23;15:1260603. doi: 10.3389/fphar.2024.1260603. eCollection 2024. Front Pharmacol. 2024. PMID: 38323083 Free PMC article.
-
Utilization patterns and prescription characteristics of traditional Chinese medicine among patients with irritable bowel syndrome in Taiwan.Front Pharmacol. 2023 Jun 16;14:1201240. doi: 10.3389/fphar.2023.1201240. eCollection 2023. Front Pharmacol. 2023. PMID: 37397480 Free PMC article.
References
-
- Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97–111. - PubMed
-
- Janson C, Lindberg E, Gislason T, et al. Insomnia in men-a 10-year prospective population based study. Sleep 2001;24:425–30. - PubMed
-
- Sofi F, Cesari F, Casini A, et al. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol 2014;21:57–64. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical